BIORA THERAPEUTICS, INC. financial data

Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 14 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 17% % -79%
Debt-to-equity -122% % 15%
Return On Equity 32% % -71%
Return On Assets -145% % 43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,522,702 shares -81%
Common Stock, Shares, Outstanding 3,677,726 shares -84%
Common Stock, Value, Issued $3,000 USD -86%
Weighted Average Number of Shares Outstanding, Basic 3,652,862 shares 143%
Weighted Average Number of Shares Outstanding, Diluted 3,652,862 shares 143%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $892,000 USD 4856%
Research and Development Expense $26,437,000 USD -10%
Operating Income (Loss) $60,873,000 USD 9.9%
Nonoperating Income (Expense) $15,446,000 USD 72%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $35,732,000 USD 70%
Income Tax Expense (Benefit) $158,000 USD -4500%
Net Income (Loss) Attributable to Parent $31,539,000 USD 74%
Earnings Per Share, Basic 39 USD/shares 90%
Earnings Per Share, Diluted 39 USD/shares 90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,000,000 USD -62%
Other Assets, Current $45,000 USD -74%
Assets, Current $6,054,000 USD -69%
Property, Plant and Equipment, Net $1,175,000 USD -4.9%
Operating Lease, Right-of-Use Asset $1,011,000 USD -45%
Goodwill $6,072,000 USD 0%
Other Assets, Noncurrent $193,000 USD -97%
Assets $14,505,000 USD -58%
Accounts Payable, Current $6,916,000 USD 77%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $120,618,000 USD 73%
Operating Lease, Liability, Noncurrent $337,000 USD -68%
Other Liabilities, Noncurrent $516,000 USD -86%
Liabilities $121,134,000 USD -21%
Retained Earnings (Accumulated Deficit) $967,084,000 USD -3.4%
Stockholders' Equity Attributable to Parent $106,629,000 USD 10%
Liabilities and Equity $14,505,000 USD -58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,496,000 USD -3.3%
Net Cash Provided by (Used in) Financing Activities $5,100,000 USD -58%
Net Cash Provided by (Used in) Investing Activities $3,005,000 USD
Common Stock, Shares Authorized 300,000,000 shares 83%
Common Stock, Shares, Issued 3,778,030 shares -84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,391,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,196,000 USD -75%
Interest Paid, Excluding Capitalized Interest, Operating Activities $78,000 USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Operating Lease, Liability $1,054,000 USD -48%
Depreciation $100,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $15,000 USD -6.2%
Lessee, Operating Lease, Liability, to be Paid $1,131,000 USD
Property, Plant and Equipment, Gross $3,580,000 USD -1.6%
Operating Lease, Liability, Current $717,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $264,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $590,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77,000 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $18,000 USD
Operating Lease, Payments $300,000 USD -25%
Operating Leases, Future Minimum Payments, Due in Two Years $590,000 USD -37%
Share-based Payment Arrangement, Expense $5,939,000 USD -65%
Operating Leases, Future Minimum Payments, Due in Three Years $264,000 USD -48%
Operating Leases, Future Minimum Payments Due $1,643,000 USD -34%
Interest Expense $7,324,000 USD -31%